ABCB1 genetic polymorphism and pharmacokinetic analysis of low dose erlotinib in frail patients with EGFR mutation (mt)-positive, non-small cell lung cancer: TORG1425

Authors :: Kazuhiko Yamada
Kei Kusaka
Shingo Miyamoto
N. Fukamatsu
Hiroaki Okamoto
Mari Ishii
Hiroshi Tanaka
T. Tokkito
Hideo Kunitoh
Tomoya Fukui
Yukio Hosomi
Hiromi Aono
Akihiro Bessho
Akinobu Hamada
Source :: Annals of Oncology. 29:viii514
Publication Year :: 2018
Publisher :: Elsevier BV, 2018.

Subjects :: business.industry
Low dose
Hematology
medicine.disease
Pharmacokinetic analysis
Oncology
Egfr mutation
medicine
Cancer research
Erlotinib
Non small cell
Lung cancer
business
medicine.drug

Full Text Access

Tools